Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients (NutriPhyT Trial)
Launched by HEIDEGGER CP · May 9, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
**Summary of the NutriPhyT Trial**
The NutriPhyT Trial is a study looking at whether better nutrition and early physical activity can help patients who have been in the intensive care unit (ICU) for a long time. As more patients survive their time in the ICU, many leave with weak muscles and a need for rehabilitation. The trial aims to see if providing more specialized nutritional support and getting patients moving sooner can improve their muscle function by the time they leave the hospital, compared to those receiving standard care.
To participate in this study, patients must be at least 18 years old, on a ventilator, and expected to stay in the ICU for at least seven days while needing special feeding methods. However, patients who are pregnant, have severe neurological issues, or other specific conditions may not be eligible. If someone joins the trial, they can expect to receive a tailored nutrition plan and early mobility support during their ICU stay, with the hope that these interventions will help them regain strength and function more effectively when they leave the hospital.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Any patient admitted to the adult ICU :
- • ≥18 years old
- • On mechanical ventilation with an expected length of stay ≥ 7 days
- • Requiring artificial nutrition (enteral and/or parenteral nutrition)
- Exclusion Criteria:
- • Therapeutic withdrawal Pregnant or breastfeeding patients
- Neurological disorders with motor deficits:
- • New or pre-existing neuromuscular or nervous system disease
- • Spinal cord injury Severe polytrauma of the lower limbs (amputation etc.) Non-independent ambulation (including walking aids) before ICU admission
- For organizational reasons not allowing follow-up :
- • Transfer to another ICU
- • Patient living abroad from Switzerland
- • Patient living in nursing homes preceding to ICU admission
- • Incarcerated patients
- • Intellectual/cognitive disabilities or language barrier, limiting ability to follow the instructions
About Heidegger Cp
Heidegger CP is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on developing novel therapies and enhancing patient outcomes, the organization partners with leading research institutions and healthcare providers to conduct rigorous clinical trials across various therapeutic areas. Committed to ethical practices and regulatory compliance, Heidegger CP prioritizes patient safety and data integrity while striving to bring transformative solutions to the healthcare market. Their expertise in trial design and execution, combined with a collaborative approach, positions Heidegger CP as a pivotal player in the evolution of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Geneva, , Switzerland
Patients applied
Trial Officials
Claudia Heidegger, MD
Principal Investigator
University Hospital, Geneva
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported